Merus N.V. (MRUS) Financial Statements (2024 and earlier)
Company Profile
Business Address |
YALELAAN 62 3584 CM UTRECHT, 3584 CM |
State of Incorp. | |
Fiscal Year End | December 31 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
6/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets | ||||||||
Cash, cash equivalents, and short-term investments, including: | 354,376 | 326,700 | 430,700 | 207,800 | 241,800 | |||
Cash and cash equivalents | 204,246 | 147,749 | 241,435 | 163,082 | 197,612 | |||
Short-term investments | 150,130 | 142,480 | 168,990 | 44,673 | 42,153 | |||
Other undisclosed cash, cash equivalents, and short-term investments | 36,471 | 20,275 | 45 | 2,035 | ||||
Receivables | 3,981 | 4,698 | 6,673 | 1,749 | 2,911 | |||
Other current assets | 1,527 | 2,204 | 2,175 | 1,058 | 1,913 | |||
Other undisclosed current assets | 8,930 | (27,159) | (15,369) | 7,386 | 744 | |||
Total current assets: | 368,814 | 306,443 | 424,179 | 217,993 | 247,368 | |||
Noncurrent Assets | ||||||||
Operating lease, right-of-use asset | 11,362 | 12,618 | 3,733 | 3,907 | 5,215 | |||
Property, plant and equipment | 12,135 | 12,222 | 3,549 | 4,115 | 3,715 | |||
Long-term investments and receivables | 57,312 | 36,457 | 20,297 | 2,009 | ||||
Long-term investments | 57,312 | 36,457 | 20,297 | 2,009 | ||||
Intangible assets, net (including goodwill) | 1,800 | 1,950 | 2,347 | 2,843 | 2,876 | |||
Intangible assets, net (excluding goodwill) | 1,800 | 1,950 | 2,347 | 2,843 | 2,876 | |||
Other undisclosed intangible assets, net (including goodwill) | ||||||||
Deferred income tax assets | 1,199 | 2,041 | 417 | 410 | ||||
Other noncurrent assets | 2,872 | 4,811 | 2,078 | 1,949 | 1,905 | |||
Other undisclosed noncurrent assets | 288 | |||||||
Total noncurrent assets: | 86,680 | 70,099 | 32,421 | 13,224 | 16,008 | |||
TOTAL ASSETS: | 455,494 | 376,542 | 456,600 | 231,217 | 263,376 | |||
LIABILITIES AND EQUITY | ||||||||
Liabilities | ||||||||
Current Liabilities | ||||||||
Accounts payable and accrued liabilities | 43,084 | 45,424 | 35,743 | 25,135 | 16,565 | |||
Taxes payable | ✕ | ✕ | ✕ | 206 | ||||
Accounts payable | 4,602 | 9,834 | 13,237 | 3,126 | 3,029 | |||
Accrued liabilities | 38,482 | 35,590 | 22,506 | 21,803 | 13,536 | |||
Deferred revenue | 22,685 | 29,418 | 16,613 | 625 | 941 | |||
Debt | 1,380 | |||||||
Due to related parties | ✕ | ✕ | 18,048 | 19,554 | 17,901 | |||
Other undisclosed current liabilities | 3,320 | 4,084 | 1,494 | 1,432 | ||||
Total current liabilities: | 69,089 | 78,926 | 71,898 | 46,746 | 36,787 | |||
Noncurrent Liabilities | ||||||||
Long-term debt and lease obligation: | 2,257 | 2,521 | 3,872 | |||||
Liabilities, other than long-term debt | 30,062 | 50,561 | 66,244 | 79,687 | 91,417 | |||
Deferred revenue | 19,574 | 38,771 | 10,962 | 237 | 780 | |||
Due to related parties | ✕ | ✕ | 55,282 | 79,450 | 90,637 | |||
Operating lease, liability | 10,488 | 11,790 | 2,257 | 2,521 | 3,872 | |||
Total noncurrent liabilities: | 30,062 | 50,561 | 68,501 | 82,208 | 95,289 | |||
Total liabilities: | 99,151 | 129,487 | 140,399 | 128,954 | 132,076 | |||
Equity | ||||||||
Equity, attributable to parent | 356,343 | 247,055 | 316,201 | 102,263 | 131,300 | |||
Common stock | 5,883 | 4,751 | 4,481 | 3,211 | 2,918 | |||
Additional paid in capital | 1,126,054 | 870,874 | 787,869 | 490,093 | 441,395 | |||
Accumulated other comprehensive income (loss) | (22,533) | (30,448) | (9,221) | 9,071 | 1,586 | |||
Accumulated deficit | (753,061) | (598,122) | (466,928) | (400,112) | (314,599) | |||
Total equity: | 356,343 | 247,055 | 316,201 | 102,263 | 131,300 | |||
TOTAL LIABILITIES AND EQUITY: | 455,494 | 376,542 | 456,600 | 231,217 | 263,376 |
Income Statement (P&L) ($ in thousands)
6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
---|---|---|---|---|---|---|---|
Revenues | 43,947 | 41,586 | 49,107 | 29,943 | 31,133 | ||
Gross profit: | 43,947 | 41,586 | 49,107 | 29,943 | 31,133 | ||
Operating expenses | (200,494) | (201,624) | (139,083) | (105,821) | (89,790) | ||
Operating loss: | (156,547) | (160,038) | (89,976) | (75,878) | (58,657) | ||
Nonoperating income (expense) | 4,800 | 29,803 | 23,399 | (9,132) | 3,700 | ||
Gain (loss), foreign currency transaction, before tax | (9,710) | 26,022 | 24,663 | ||||
Other nonoperating income (expense) | 1,059 | (1,135) | (9,132) | 3,700 | |||
Loss from continuing operations before income taxes: | (151,747) | (130,235) | (66,577) | (85,010) | (54,957) | ||
Income tax expense | (3,192) | (959) | (239) | (503) | (194) | ||
Loss from continuing operations: | (154,939) | (131,194) | (66,816) | (85,513) | (55,151) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (66,816) | (85,513) | (55,151) | |
Net loss available to common stockholders, diluted: | (154,939) | (131,194) | (66,816) | (85,513) | (55,151) |
Comprehensive Income ($ in thousands)
6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
---|---|---|---|---|---|---|---|
Net loss: | (154,939) | (131,194) | (66,816) | (85,513) | (55,151) | ||
Other undisclosed comprehensive income (loss) | 7,915 | (21,227) | (18,292) | 7,485 | (1,308) | ||
Comprehensive loss, net of tax, attributable to parent: | (147,024) | (152,421) | (85,108) | (78,028) | (56,459) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.